Fuyuan Pharmaceutical announced that the company participated in the bidding for the tenth batch of national centralized Pharmaceutical procurement, and the product Telmisartan and Hydrochlorothiazide tablets is expected to be selected.
福元医药：公司产品替米沙坦氢氯噻嗪片拟中选第十批全国药品集中采购
Fuyuan Pharmaceutical: The company's product, Telmisartan and Hydrochlorothiazide tablets, is expected to be selected in the tenth batch of national centralized Pharmaceutical procurement.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated